An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome

Drexel, Heinz; Coats, Andrew J S; Spoletini, Ilaria; Bilato, Claudio; Mollace, Vincenzo; Filardi, Pasquale Perrone; Rosano, Giuseppe M C (2020). An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome. European heart journal - cardiovascular pharmacotherapy, 6(2), pp. 115-121. Oxford University Press 10.1093/ehjcvp/pvz079

[img]
Preview
Text
DrexelH_ESCPositionPaperonStatinAdherence_EurHeartJCardioPharm_2019.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (963kB) | Preview

Benefits and safety on statins have been well established over 20 years of research. Despite this, the vast majority of patients are not adequately treated and do not achieve the low-density lipoprotein cholesterol target levels. This is mainly due to poor adherence, which is associated with dangerous and sometimes fatal outcomes. To increase adherence and prevent worse outcomes, a combination therapy with lower dosage of statins and new lipid lowering drugs may be used. However, the implementation of new lipid lowering drugs in European countries is still at the beginning. For these reasons, aim of this position paper is to give an up-to-date indication from the European Society of Cardiology in order to discuss the barriers towards statins adherence and new lipid lowering drugs implementation in Europe.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Drexel, Heinz

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2055-6837

Publisher:

Oxford University Press

Language:

English

Submitter:

Isabel Lorenz

Date Deposited:

16 Jan 2020 09:48

Last Modified:

05 Dec 2022 15:35

Publisher DOI:

10.1093/ehjcvp/pvz079

PubMed ID:

31873726

Uncontrolled Keywords:

PCSK9 inhibitors Statins adherence ezetimibe low-density lipoprotein cholesterol position paper statin intolerance

BORIS DOI:

10.7892/boris.137824

URI:

https://boris.unibe.ch/id/eprint/137824

Actions (login required)

Edit item Edit item
Provide Feedback